Expert Radar
Dr. Timothy Fenske, MD, MS
Barnes-Jewish Hospital
Bachelor of Science, Marquette University
Dr. Timothy Fenske has 20 years of experience in the field of Hematology and Medical Oncology. He earned his BS from Marquette University and his MD and MS from the University of Wisconsin, Madison. He completed his residency in Internal Medicine at the University of Wisconsin, Madison Hospitals and his fellowship in Hematology and Oncology at the Washington University School of Medicine Barnes-Jewish Hospital. Today this expert is board certified in Medical Oncology. Formerly this expert held roles as an Assistant Professor of Hematology and Oncology at the Medical College of Wisconsin and as Section Head of Hematologic Malignancies and BMT at the same institution. Currently, he serves as a Clinical Professor of Hematology and Oncology at the Medical College of Wisconsin.
t*********@***.edu
(414) ***-****
Milwaukee, Wisconsin
Get a FREE Demo of Dr. Timothy Fenske, MD, MS's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
8
Expert Challenges
8
Deposition Transcripts
Publications
173
Media & News
455
Social Media Mentions
1264
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 173 records
Title | Type |
---|---|
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation | Journal Article |
Anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed or refractory large B-cell lymphoma: A multicenter study | Journal Article |
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 455 records
Title | Description |
---|---|
High-dose chemo + autologous stem cell therapy ... | Dec 13, 2024 ----- Timothy S. Fenske , Medical College of Wisconsin, presented findings ... Annual Meeting and Exposition in San Diego. To access this ... |
ASH 2024 | Dec 12, 2024 ----- Keynote series | Spotlight on menopause ... Timothy Fenske reports phase 3 data ... Refresh your knowledge in Oncology and Hematology . |
Can we omit auto-SCT in patients with mantle cell lymphoma ... | Dec 12, 2024 ----- ... Timothy Fenske (Medical College of Wisconsin , WI , USA). The initial findings of the EA4151 trial indicate that auto-SCT does not benefit ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
Marquette University | Bachelor of Science |
University of Wisconsin Madison | Doctor of Medicine |
University of Wisconsin Madison | Master of Science |
Title | Employer |
---|---|
— | Barnes-Jewish Hospital |
MCW Institutional Principal Investigator | Wisconsin Oncology Network |
MCW Institutional Principal Investigator | Eastern Cooperative Oncology Group |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.